| Factor Information | |
|---|---|
| Data ID | 1274 |
| Factor | Percent of surgical procedures (≥3) |
| Description | In addition, patients ≥3 or more surgeries a 2.5 times higher risk (OR 2.5, 95% CI 1.1– 5.5; p=0.027) |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | more prolonged QRS complexes |
| p Value | <0.05 |
| OR | >2.0 |
| Conclusion | the presence of fQRS on ECG may be a useful tool in daily clinical practice to identify patients at risk for developing VTA in patients with CHD, in addition to known predictors of VTA |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 510 |
| CHD Type | isolated CHD |
| CHD Subtype | AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
| Reference | |
|---|---|
| PMID | 27780553 |
| Year | 2016 |
| Title | Usefulness of Fragmented QRS Complexes in Patients With Congenital Heart Disease to Predict Ventricular Tachyarrhythmias. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Data | |
| Region | Rotterdam, Netherlands | |
| Method | retrospective case-control study | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | ventricular tachyarrhythmia (VTA)(Treatment) | controls(Control) |
| Number | 48(total:139) | 33(total:219) |
| Age | mean age: 39±14 years | mean age: 38±14 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 48(35%) | 33(15%) |
